United StatesÚltimas notícias

The Buckle (NYSE:BKE) reported positive sales figures for the four-week fiscal month ended May 30, 2026, marking a continued period of growth for the retailer.

Caleres (NYSE:CAL), a portfolio of consumer-driven footwear brands, reported financial results for the first quarter of 2026 today, highlighted by a significant performance gap between its wholesale brand operations and its retail footprint.

Bio-Techne (NASDAQ:TECH) and Refeyn have launched a new integrated analytical workflow designed to streamline the characterization of complex biologics.

Iran said there had been no recent progress in talks over an interim peace deal with the US, while fighting persisted in Lebanon despite Washington's declaration of a ceasefire between the country and Israel. Abeer Abu Omar reports on Bloomberg Television.

Columbus McKinnon (NASDAQ:CMCO) reported its financial results for the fourth quarter and full fiscal year 2026 today, highlighting the substantial impact of its recent Kito Crosby acquisition.

MarketAxess Holdings (NASDAQ:MKTX) saw a broad rebound in trading volumes across most product categories during May 2026, recovering from levels recorded in April.

Somnigroup International (NYSE:SGI) announced today that its proposed acquisition of Leggett & Platt (NYSE:LEG) has cleared a significant regulatory hurdle.

X-energy (NASDAQ:XE) reported total revenues and grant income of $43.4 million for the first quarter of 2026, marking a 109% increase compared to the same period in 2025.

Former Health Minister Wes Streeting vowed he would fight a battle against Mayor of Greater Manchester Andy Burnham if the two went head-to-head in a race for the leadership of the governing Labour Party. "He needs to set out his stall, I need to set out mine," Streeting said in conversation with Bloomberg's Francine Lacqua at the SXSW London tech festival Wednesday.

Sophie Huynh, senior cross asset strategist at BNP Paribas Asset Management, discusses the risk of a so-called bubble in the artificial intelligence trade space. "What I'm looking at much more is tokens rationing," she tells Bloomberg Television. "There's anecdotes here and there that we're consuming so much tokens at this point that there's not going to be enough," Huynh says. She also discusses the impact of the ongoing conflict in the Middle East on markets.

Alvotech (NASDAQ:ALVO) has officially resubmitted its Biologics License Applications (BLAs) to the U.S. Food and Drug Administration (FDA) for two of its lead biosimilar candidates: AVT05, a proposed biosimilar to Simponi and Simponi Aria (golimumab), and AVT06, a proposed biosimilar to Eylea (aflibercept) 2 mg.

111 (NASDAQ:YI) reported unaudited financial results for the first quarter of 2026 today, signaling the company's deepening transition toward a more lean and technology-oriented operating structure.